文献速递乳腺病理细胞病理与分子病理

乳腺标本细针穿刺活检可高效获取细胞用于导管原位癌类器官建模

FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ.
PubMed 文献 · Cancer Cytopathol · 2025-01-01

本研究以活检证实的导管原位癌(DCIS)手术标本为对象,比较细针穿刺活检(FNAB)与空心针活检(CNB)获取细胞构建患者来源类器官(PDO)的效率。CNB在18例中15例、FNAB在11例中7例成功生成PDO;FNAB起始生长平均4天,CNB为19.3天,提示FNAB是高效替代方式。

要点

  • FNAB与CNB均可从DCIS标本成功构建PDO,FNAB起始生长更快。
  • FNAB涂片7/11、CNB触片16/18可见肿瘤细胞。
  • 免疫荧光证实PDO同时含腔面与肌上皮细胞。

核心结论

  • FNAB可有效获取细胞用于DCIS类器官建模,且起始生长时间明显短于CNB。

研究设计与样本

  • 取自活检证实DCIS患者的手术标本,手术室对新鲜标本行CNB并机械解离后培养于BME与类器官培养基。
  • 病理取材室对新鲜标本行FNAB,穿刺液同样送培养以生成PDO。

主要发现

  • CNB获取的18例标本中15例成功生成PDO,FNAB获取的11例中7例成功生成PDO。
  • FNAB标本起始类器官生长平均4天,CNB标本为19.3天。
  • FNAB涂片11例中7例见肿瘤细胞,CNB触片18例中16例见肿瘤细胞。
  • 免疫荧光染色证实所得PDO中存在腔面细胞与肌上皮细胞。

临床怎么用

  • FNAB可作为乳腺PDO培养的高效替代取材方式,有望减少构建PDO所需时间与资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-derived organoids (PDOs) generated from benign breast tissue and breast carcinomas have successfully recapitulated their in vivo counterparts. PDOs model tumorigenesis and allow for screening novel therapeutics personalized to individual patients. However, acquiring cells to generate PDOs is cumbersome. This study demonstrates the feasibility of fine-needle aspiration biopsy (FNAB) for harvesting cells for PDOs modeling ductal carcinoma in situ (DCIS) and compares the efficacy with core needle biopsy (CNB). METHODS: Surgical specimens from patients with biopsy-proven DCIS were used for this study. CNB was performed on fresh specimens in the operating room, and tissue was mechanically dissociated before culture in basement membrane extract (BME) and organoid medium to generate PDOs. FNAB was performed in the pathology gross room on fresh specimens, and the aspirate was similarly submitted for culture. RESULTS: PDOs were successfully generated in 15 of 18 specimens obtained by CNB and seven of 11 specimens obtained by FNAB. The average time to initial organoid growth was 4 days for FNAB specimens compared to 19.3 days for CNB specimens. Tumor cells were seen on seven of 11 FNAB smears and 16 of 18 CNB touch preps. Immunofluorescence staining confirmed the presence of both luminal and myoepithelial cells in derived PDOs. CONCLUSIONS: FNAB effectively obtains cells for PDOs modeling DCIS. CNB yielded PDOs with a high success rate, but they were slow to establish. The time to organoid growth was significantly shorter for FNAB specimens. Thus, FNAB offers an efficient alternative for breast PDO culture and can reduce the time and resources spent on generating PDO cultures.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Ye J, Goldhammer N, Vohra P, et al. FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ. Cancer Cytopathol. 2025. PMID: 41066221. doi:10.1002/cncy.70052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。